Respiratory conditions - quality prescribing strategy: improvement guide 2024 to 2027
Respiratory conditions are a major contributor to ill health, disability, and premature death – the most common conditions being asthma and COPD. This quality prescribing guide is designed to ensure people with respiratory conditions are at the centre of their treatment.
9. Respiratory Prescribing Data for NHS Health Board
This chapter contains some top-level prescribing information comparing NHS Boards. Chart 12 below highlights the cost per treated patient which has decreased by £17.00 in NHS Scotland between 2020/21 and 2022/23.
Generic Prescribing
National and local guidance promotes branded prescribing of all inhalers excluding salbutamol inhalers. This ensures that the correct inhaler device and product is given to the individual (e.g. formulations of inhaled corticosteroids differ in potency). Chart 13 shows prescribing of generic inhalers across health boards, showing improvements across all boards.
Contact
Email: EPandT@gov.scot
There is a problem
Thanks for your feedback